Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Laforêt

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Neurology|May 26, 2022
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe DiseaseMazen M Dimachkie, Richard J Barohn, Barry Byrne, et al.
European Journal of Neurology|October 27, 2025
Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective StudyDiana Maria Chitimus, Céline Tard, Maxime Fournier, et al.
Neuroimage. Clinical|December 8, 2018
The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging studyGiorgia Querin, Mohamed-Mounir El Mendili, Timothée Lenglet, et al.
Annals of Neurology|October 5, 2012
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging FindingsFanny Mochel, Raphael Schiffmann, Marjan E Steenweg, et al.
Neurology|July 7, 2023
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022Claire Lefeuvre, Marie De Antonio, Francoise Bouhour, et al.
European Journal of Neurology|August 7, 2024
Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registryEmilie Retailleau, Claire Lefeuvre, Marie De Antonio, et al.
Orphanet Journal of Rare Diseases|November 25, 2020
Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)Renata S Scalco, Alejandro Lucia, Alfredo Santalla, et al.
Brain : a Journal of Neurology|January 14, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CSerge Herson, Faycal Hentati, Aude Rigolet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2013
Hereditary myopathy with early respiratory failure: occurrence in various populationsJohanna Palmio, Anni Evilä, Françoise Chapon, et al.
Orphanet Journal of Rare Diseases|July 24, 2023
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participationWalaa Karazi, Renata S Scalco, Mads G Stemmerik, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Neurology|May 26, 2022
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe DiseaseMazen M Dimachkie, Richard J Barohn, Barry Byrne, et al.
European Journal of Neurology|October 27, 2025
Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective StudyDiana Maria Chitimus, Céline Tard, Maxime Fournier, et al.
Neuroimage. Clinical|December 8, 2018
The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging studyGiorgia Querin, Mohamed-Mounir El Mendili, Timothée Lenglet, et al.
Annals of Neurology|October 5, 2012
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging FindingsFanny Mochel, Raphael Schiffmann, Marjan E Steenweg, et al.
Neurology|July 7, 2023
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022Claire Lefeuvre, Marie De Antonio, Francoise Bouhour, et al.
European Journal of Neurology|August 7, 2024
Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registryEmilie Retailleau, Claire Lefeuvre, Marie De Antonio, et al.
Orphanet Journal of Rare Diseases|November 25, 2020
Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)Renata S Scalco, Alejandro Lucia, Alfredo Santalla, et al.
Brain : a Journal of Neurology|January 14, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CSerge Herson, Faycal Hentati, Aude Rigolet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2013
Hereditary myopathy with early respiratory failure: occurrence in various populationsJohanna Palmio, Anni Evilä, Françoise Chapon, et al.
Orphanet Journal of Rare Diseases|July 24, 2023
Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participationWalaa Karazi, Renata S Scalco, Mads G Stemmerik, et al.
Pageof 17